BLADDER TRANSITIONAL CELL CARCINOMA RECURRENT

This adverse event was reported 102 times

These drugs are most commonly taken by patients reporting BLADDER TRANSITIONAL CELL CARCINOMA RECURRENT:

# Drug Count
0 METHOTREXATE SODIUM 17
1 METHOTREXATE 15
2 ETANERCEPT 10
3 LAMIVUDINE 8
4 ASPIRIN 7
5 ASPIRIN 325 MG 7
6 ASPIRIN 81 MG 7
7 VALSARTAN 7
8 BARICITINIB 6
9 LAMIVUDINE ORAL 6
See all common drugs associated with BLADDER TRANSITIONAL CELL CARCINOMA RECURRENT

BLADDER TRANSITIONAL CELL CARCINOMA RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BACILLUS CALMETTE-GUERIN 5 0.0028
1 GEMCITABINE INTRAVESICAL 1 0.0021
2 BARICITINIB 6 0.0020
3 UREA 4 0.0018
4 SILODOSIN 4 0.0010
5 PIOGLITAZONE AND METFORMIN HYDROCHLORIDE 1 0.0008
6 CEFOXITIN SODIUM 1 0.0007
7 MITOMYCIN 2 0.0005
8 ENFORTUMAB VEDOTIN 4 0.0005
9 TERAZOSIN HYDROCHLORIDE 4 0.0004
See all drugs enriched for association with BLADDER TRANSITIONAL CELL CARCINOMA RECURRENT